Search Results - "Danziger, N.A."

573P Panorama of genomic RET alterations (GA) in the major subtypes of thyroid carcinomas (TC) by Bowles, D.W., Sivapiragasam, A., Danziger, N.A., Pavlick, D., Ross, J.S.

Get full text

282P Methylthioadenosine phosphorylase (MTAP) genomic loss in ERBB2 amplified (amp) and mutated (mut) (ERBB2+) metastatic breast cancer (MBC) by Sivapiragasam, A., Danziger, N.A., Mcgregor, K., Sokol, E., Ross, J.S.

Get full text

660MO Molecular targets in salivary gland cancers: A comprehensive genomic analysis of 1,666 cases by Sivapiragasam, A., Ashok Kumar, P., Bou Zerdan, M., Zaccarini, D.J., Danziger, N.A., Ross, J.S.

Get full text

771P Genomic characterization of advanced endometrial carcinosarcoma: Identification of potentially actionable targets by De Giorgi, U.F.F., Kuang, Z., Danziger, N.A., Moore, J.A., Lin, D.I., Mangili, G., Pignata, S., Sokol, E.S., Sivakumar, S.

Get full text

690P Comprehensive genomic profiling (CGP) of VHL mutated and VHL wild type clear cell renal cell carcinoma (ccRCC) by Bratslavsky, G., Grivas, P., Spiess, P.E., Decker, B., Danziger, N.A., Sokol, E., Ross, J.S.

Get full text

1521P Comprehensive genomic profiling (CGP) of epithelioid hemangioendothelioma (EHE) and liver angiosarcomas (LAS) by Shreenivas, A., Kurzrock, R., Chen, H-Z., Clark, A., K. Dougherty, Danziger, N.A., Chakrabarti, S., Charlson, J., Ross, J.S.

Get full text

1710P Genomic landscape (GL) with potential of methylthioadenosine phosphorylase (MTAP) loss in clinically advanced breast cancer (CABC) by Bou Zerdan, M., Ashok Kumar, P., Sokol, E.S., Pavlick, D.C., Levy, M., Danziger, N.A., Ross, J.S., Sivapiragasam, A.

Get full text

1778P Comparative genomic alterations (GA) landscape in urothelial carcinoma of the bladder (UCB) in patients of South Asian ancestry (SAS) by Spiess, P.E., Bratslavsky, G., Grivas, P., Jacob, J., Necchi, A., Danziger, N.A., Pavlick, D.C., Tukachinsky, H., Graf, R.P., Ross, J.S.

Get full text

1393P Comparison of genomic alterations (GA) landscape in SPOP mutated (SPOPmut) and SPOP wild type (SPOPwt) clinically advanced prostate cancer (CAPC) by Bratslavsky, G., Spiess, P.E., Grivas, P., Jacob, J., Necchi, A., Danziger, N.A., Pavlick, D.C., Tukachinsky, H., Graf, R.P., Ross, J.S.

Get full text

134P In search of novel Synthetic Lethality (SL) anti-cancer drug targets: MTAP Genomic Alterations (GA) in human malignancies by Sokol, E.S., Madison, R., Pavlick, D.C., Danziger, N.A., Schrock, A.B., Ross, J.S.

Get full text

891P Landscape of NOTCH1 genomic alterations (GA) in head and neck squamous cell carcinoma (HNSCC) and T-ALL by Ikenberg, K., Bratslavsky, G., Jacob, J., Danziger, N.A., Necchi, A., Spiess, P.E., Grivas, P., Pauli, C., Moch, H., Ross, J.S.

Get full text

2400P Frequency and nature of genomic alterations (GA) in ERBB2-altered urothelial bladder cancer (UBC) by Talukder, R., Leary, J., Enright, T., Bakaloudi, D.R., Bratslavsky, G., Jacob, J.M., Spiess, P., Li, R., Necchi, A., Kamat, A., Pavlick, D.C., Danziger, N.A., Huang, R., Lin, D.I., Ross, J.S., Grivas, P.

Get full text

738P Penile squamous cell carcinoma with high and very high tumor mutational burden (TMB): A genomic landscape and "real-world" clinical outcome study by Jacob, J.M., Spiess, P., Padua, T.C.D., Li, R., Grivas, P., Huang, R., Lin, D.I., Danziger, N.A., Ross, J.S., Li, G., Graf, R.P., Pavlick, D.C., Basnet, A., Bratslavsky, G., Necchi, A.

Get full text

2395P Micropapillary histology (MPUC) and extra-cellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC) by Sood, A., Jacob, J.M., Bratslavsky, G., Grivas, P., Spiess, P., Li, R., Necchi, A., Posada, J., Yakirevich, E., Cheng, L., Pavlick, D.C., Huang, R., Lin, D.I., Danziger, N.A., Sokol, E.S., Sivakumar, S., Ross, J.S., Kamat, A.

Get full text

305P Patterns of acquired mutations in estrogen receptor-positive metastatic breast cancer (MBC) patients identified by comprehensive genomic profiling (CGP) by McGregor, K., Ross, J.S., Danziger, N.A., Sokol, E.S., Venstrom, J., Chung, J.H., Lee, J., Alexander, B., Schrock, A.B., Tukachinsky, H.

Get full text

710P Comprehensive genomic profiling (CGP) of small cell neuroendocrine carcinoma of the bladder (NEBC) by Necchi, A., Grivas, P., Bratslavsky, G., Spiess, P.E., Millis, S., Hoffman-Censits, J., Gupta, S., Decker, B., Danziger, N.A., Ross, J.S.

Get full text

237P Real-world outcomes of hormone receptor-positive (HR+) HER2-negative (HER2-) metastatic breast cancer (mBC) with high tumor mutational burden (hTMB) treated with immune checkpoint inhibitors (ICI) by Chumsri, S., Sammons, S., Alder, L., Sokol, E., Danziger, N.A., Raskina, K., Schrock, A.B., Venstrom, J., Snow, T., Castellanos, E., Ochuonyo, E., Snider, J., Mcgregor, K.

Get full text

694P Methylthioadenosine phosphorylase (MTAP) deletion is more common in sarcomatoid (srcRCC) than in clear cell renal cell carcinoma (ccRCC) by Necchi, A., Grivas, P., Spiess, P.E., Jacob, J., Sokol, E., Ramkissoon, S., Severson, E., Huang, R.S.P., Lin, D.I., Mata, D.A., Decker, B., Mcgregor, K., Danziger, N.A., Ross, J.S., Bratslavsky, G.

Get full text

130P PTCH1 Genomic Alterations (GA) in human malignancies: A pangenomic study by Ross, J.S., Sokol, E.S., Pavlick, D.C., Vergilio, J-A., Killian, J.K., Williams, E., Danziger, N.A., Tse, J., Ramkissoon, S., Severson, E., Hemmerich, A., Duncan, D., Huang, R., Madison, R., Schrock, A.B., Alexander, B., Venstrom, J., Reddy, P., McGregor, K., Elvin, J.

Get full text

957P Ameloblastoma of the head and neck (HNAMB): A comprehensive profiling (CGP) study by Reddy, P., Danziger, N.A., Elvin, J., Vergilio, J-A., Killian, J.K., Lin, D.I., Williams, E., Ramkissoon, S., Severson, E., Hemmerich, A., Duncan, D., Edgerly, C., Huang, R., Hiemenz, M., Chung, J.H., McGregor, K., Venstrom, J., Schrock, A.B., Alexander, B., Ross, J.S.

Get full text